‘The luckiest of the unlucky’: A Duchenne gene therapy brings hope to families — and tests the FDA
Bio Pharma Dive
MAY 7, 2023
Patient advocates and doctors are anticipating an approval this month of a treatment they believe to be a breakthrough for a deadly disease. But it’s not clear how well the therapy really works, putting the FDA in a difficult position.
Let's personalize your content